IPO registrations (S-1, F-1) · Registrants
Immunome Inc.
- SEC CIK
- 1472012 · filings on EDGAR ↗
- Registration
- Form S-1, first filed 2020-09-09, last 2021-05-26; 2 initial registrations, 3 amendments
- Outcome
- Final prospectus filed 2020-10-05; declared effective 2020-10-01
- Industry (SIC)
- Pharmaceutical Preparations 2834
- Incorporated in
- DE
- Business address
- 18702 N. CREEK PARKWAY, SUITE 100, Bothell, WA 98011
- EIN
- 77-0694340
- Ticker
- IMNM (Nasdaq)
- EDGAR entity type
- operating
- Insiders and CEO pay
- Immunome Inc. on the corporate pages
Offering terms
- Proposed price range
- $11.00–$13.00 per share (S-1/A filed 2020-09-24)
- Final price
- $12.00 per share, within the range (424B4 filed 2020-10-05, an initial public offering)
- Shares sold
- 3,250,000
- Gross proceeds
- $39,000,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol IMNM
- Lead underwriters
- Ladenburg Thalmann (2,275,000 shares); Chardan (975,000 shares)
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: IMMUNOME, INC. EXACT (EIN (EXACT, as the state registration reports it))
- Business registration: Immunome, Inc. Fuzzy (name and state)
- Business registration: Immunome, Inc. Fuzzy (name and state)
- Business registration: IMMUNOME INC Fuzzy (name and state)
- Business registration: IMMUNOME, INC. Fuzzy (name and state)
- Business registration: IMMUNOME, INC. Fuzzy (name and state)
- Business registration: IMMUNOME, INC. Fuzzy (name and state)
- Form 5500 plan sponsor: IMMUNOME, INC. EXACT (EIN (EXACT))
- Form D issuer: Immunome Inc. EXACT (CIK (EXACT))
- SEC filer: Immunome Inc. EXACT (CIK (EXACT))
- Person page: John L Lamattina Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
Filings 10
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2020-09-09 | S-1 | S-1 (registration) | Immunome Inc. | 0001104659-20-103458 ↗ |
| 2020-09-24 | S-1/A | S-1/A (amendment) | Immunome Inc. | 0001104659-20-108076 ↗ |
| 2020-10-01 | S-1MEF | S-1MEF (added securities) | Immunome Inc. | 0001104659-20-111245 ↗ |
| 2020-10-01 | EFFECT | EFFECT (declared effective) | Immunome Inc. | 9999999995-20-002651 ↗ |
| 2020-10-05 | 424B4 | 424B4 (final prospectus) | Immunome Inc. | 0001104659-20-112273 ↗ |
| 2021-05-11 | S-1 | S-1 (registration) | Immunome Inc. | 0001104659-21-064661 ↗ |
| 2021-05-21 | S-1/A | S-1/A (amendment) | Immunome Inc. | 0001104659-21-070466 ↗ |
| 2021-05-26 | S-1/A | S-1/A (amendment) | Immunome Inc. | 0001104659-21-072480 ↗ |
| 2021-06-01 | EFFECT | EFFECT (declared effective) | Immunome Inc. | 9999999995-21-002172 ↗ |
| 2021-10-14 | EFFECT | EFFECT (declared effective) | Immunome Inc. | 9999999995-21-003887 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2020-09-24 | S-1/A | registration statement | $11.00–$13.00 | 2,500,000 | - | Nasdaq IMNM | 2 | primary document; range, shares headline, cover names 2 | document ↗ | |
| 2020-10-05 | 424B4 | final prospectus | $12.00 | 3,250,000 | $39,000,000 | Nasdaq IMNM | 2 | primary document; price sentence, shares headline, proceeds table, underwriting table 2, cover names 2 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| BARON RICHARD A | Director | 6 | 2020–2023 | ||
| Fitzgerald Richard F | Officer | Chief Financial Officer | 2 | 2020 | |
| LAMATTINA JOHN L | Director | 8 | 2020–2023 | person page Fuzzy | |
| Lefenfeld Michael | Director | 8 | 2020–2023 | ||
| Morin Michael | Officer | Chief Scientific Officer | 1 | 2020 | |
| MORRIS I WISTAR III | TenPercentOwner | 2 | 2020 | ||
| RAPP MICHAEL | Director; Director,TenPercentOwner | 11 | 2020–2023 | ||
| Sarma Purnanand D | Director,Officer | president and CEO; President and CEO | 5 | 2020–2023 | |
| WAGENHEIM PHILIP | Director | 11 | 2020–2026 | ||
| Widlitz Michael | Director | 4 | 2020–2021 | ||
| Stoneman Sandra G. | Officer | CHIEF LEGAL OFFICER & GC; Chief Legal Officer & Gen Coun; General Counsel and CLO | 10 | 2020–2026 | |
| Marcou Diane M | Officer | Interim CFO | 1 | 2020 | |
| Giesing Dennis H | Officer | Chief Development Officer | 5 | 2021–2023 | |
| Roche Corleen M. | Officer | Chief Financial Officer | 5 | 2021–2023 | |
| PRENDERGAST FRANKLYN G | Director | 5 | 2021–2023 | ||
| ROBINSON MATTHEW K | Officer | Chief Technology Officer | 3 | 2022–2023 | |
| SIEGALL CLAY B | Director,Officer | President and CEO | 13 | 2023–2026 | |
| Turner Bruce | Officer | Chief Strategy Officer | 3 | 2023–2024 | |
| Barchas Isaac | Director; Director,Other | 10 | 2023–2026 | ||
| Boylan James P | Director | 5 | 2023–2026 | ||
| Higgins Jack | Officer | Chief Scientific Officer | 12 | 2023–2026 | |
| Rosett Max | Officer | Chief Financial Officer; EVP, Operations & CFO; EVP, OPERATIONS & INTERIM CFO; SVP Operations | 9 | 2023–2026 | |
| Lechleider Robert | Officer | Chief Medical Officer | 8 | 2023–2026 | |
| BIENAIME JEAN JACQUES | Director | 13 | 2023–2026 | ||
| Roberts Phil Noland | Officer | Chief Technology Officer | 2 | 2023 | |
| Lapetina Bob | Officer | PAO and VP Finance & Corporate | 1 | 2024 | |
| SCHAFER CAROL | Director | 5 | 2024–2026 | ||
| Horn Kinney | Officer | CHIEF BUSINESS OFFICER | 7 | 2024–2026 | |
| SWAIN SANDRA M | Director | 5 | 2024–2026 | ||
| Tsai Philip | Officer | Chief Technical Officer; Chief Technology Officer | 7 | 2024–2026 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2021-05-11 | Immunome Inc. | Biotechnology | $27,000,054 | $27,000,054 | 47 | 1 |
| 2020-06-01 | Immunome Inc. | Biotechnology | $11,000,000 | $11,000,000 | 49 | 2 |
| 2019-11-19 | Immunome Inc. | Biotechnology | $16,800,000 | $9,300,000 | 35 | 1 |
| 2019-02-01 | Immunome Inc. | Biotechnology | $6,500,000 | $6,500,000 | 27 | 2 |
| 2017-05-30 | Immunome Inc. | Biotechnology | $5,000,000 | $5,000,000 | 48 | 1 |
| 2016-07-14 | Immunome Inc. | Biotechnology | $12,000,000 | $5,057,508 | 27 | 1 |
| 2015-12-02 | Immunome Inc. | Biotechnology | $8,500,000 | $3,634,048 | 18 | 1 |
| 2014-10-14 | Immunome Inc. | Pharmaceuticals | $1,062,500 | $892,500 | 17 | 2 |
| 2014-03-03 | Immunome Inc. | Pharmaceuticals | $800,000 | $735,000 | 23 | 2 |
| 2012-01-27 | Immunome Inc. | Pharmaceuticals | $1,500,000 | $145,000 | 4 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Business registration | Immunome, Inc. | WA | State business registries | name and state |
| Business registration | Immunome, Inc. | WA | State business registries | name and state |
| Business registration | IMMUNOME INC | WA | State business registries | name and state |
| Business registration | IMMUNOME, INC. | WA | State business registries | name and state |
| Business registration | IMMUNOME, INC. | WA | State business registries | name and state |
| Business registration | IMMUNOME, INC. | WA | State business registries | EIN (EXACT, as the state registration reports it) |
| Business registration | IMMUNOME, INC. | WA | State business registries | name and state |
| Form D issuer | Immunome Inc. | MA | Form D private offerings | CIK (EXACT) |
| Patent assignee | Immunome, Inc. | WA | Patents (USPTO) | name and state |
| SEC filer | Immunome Inc. | SEC filers (EDGAR) | CIK (EXACT) | |
| Trademark owner | Immunome, Inc. | WA | Trademarks (USPTO) | name and state |
| Form 5500 plan sponsor | IMMUNOME, INC. | EIN (EXACT) | ||
| Person page | John L Lamattina | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.